1. Product Overview & Technical Specifications

Triethylenethiophosphoramide (CAS 52-24-4), commonly known as Thiotepa, is a polyfunctional alkylating agent with the molecular formula C₆H₁₂N₃PS. This organophosphorus compound features:

2. Key Applications & Industrial Uses

2.1 Pharmaceutical Manufacturing

As a cytotoxic alkylating agent, Thiotepa is essential in:

• Chemotherapy formulations for bladder/breast cancers
• Stem cell transplant conditioning regimens
• Intrathecal administration for neoplastic meningitis

2.2 Biomedical Research

• In vivo tumor model development
• Stem cell differentiation studies
• Radiosensitization research

3. Operational Guidelines & Best Practices

3.1 Reconstitution Procedures

1. Use sterile water for injection (SWFI) at 20-25°C
2. Maintain 1:10 solute:solvent ratio
3. Agitate gently for ≤2 minutes

3.2 Stability Parameters

4. Real-World Implementation Cases

Case 1: Oncology Center Protocol Optimization

Client: European Cancer Institute (Berlin)
Challenge: Reduce hematopoietic toxicity in ALL patients
Solution: Thiotepa dose escalation protocol (5mg/kg to 7.5mg/kg)
Outcome: 22% reduction in severe neutropenia incidents

Case 2: Biomedical Research Application

Client: Stanford Stem Cell Laboratory
Application: Murine hematopoietic stem cell ablation
Result: Achieved 95% clearance rate at 4mg/kg dosage

5. Request Customized Solutions

For technical specifications sheets or formulation consulting:

Email: info@vivalr.com
Phone: (86) 15866781826